Updated Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDAC ® Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Presentation Date and ...

Barclays initiated coverage of C4 Therapeutics (CCCC) with an Overweight rating and $8 price target The company’s lead asset, cemsidomide is an ...

Investing.com -- C4 Therapeutics (NASDAQ:CCCC) stock rose 13% Monday after Stephens analyst Sudan Loganathan upgraded the company from Equal Weight to Overweight with a price target of $6.00, ...

For White, who possesses the advantage of the first move, hypermodern openings offer a unique blend of flexibility and ...

The Regulator of Social Housing has issued a C4 grading to Tandrige District Countil. The Regulator of Social Housing has ...

Baystreet.ca News Commentary – Recent cuts to public cancer research funding are reshaping the oncology landscape as ...

A BOMBSHELL documentary on The X Factor is being made, with Simon Cowell being lined up to ensure the show is a definitive history of the TV phenomenon. I can reveal that Sky is developing the ...

HealthDay News — For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical gemcitabine-releasing system, TAR-200 monotherapy, ...

Eleven early-career researchers at the University of Oxford have been awarded highly competitive ERC Starting Grants ...

This article explores advanced oligonucleotide analysis techniques, including chromatography methods for therapeutic RNA, ...

A home in Tiverton, on Puncatest Neck Road, sold for $4,500,000. This home has eight bedrooms, three and a half bathrooms, ...

SIOUX CITY (KTIV) - Dr. Juan Córdova, the recently hired new superintendent for Sioux City’s public schools, has returned ...